Clinical Trials
17 trialsNCT02338518 2023-09-29
SVOSA
Jinling Hospital, China
Phase 3 Unknown
NCT05472896 2022-07-25
TACE With Dicycloplatin(TP21) in Unresectable HCC
Zhongda Hospital
Phase 3 Unknown
NCT05053386 2021-09-22
Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma
Zhejiang Cancer Hospital
Phase NA Unknown
NCT04738188 2021-02-04
Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;
Beijing Tsinghua Chang Gung Hospital
Phase NA Unknown
NCT02971345 2020-06-11
Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
Shanghai Zhongshan Hospital
Phase 3 Unknown
NCT02177552 2019-02-15
SEED
Rigshospitalet, Denmark
Phase 2 Unknown
NCT03668418 2018-09-12
xenoZ
University of Pisa
Unknown
NCT03192644 2017-06-20
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
Sun Yat-sen University
Phase 3 Unknown
NCT00450203 2016-12-01
ST03
Medical Research Council
Phase 2/3 Unknown
NCT02949258 2016-10-31
NCT-B4
Jinling Hospital, China
Phase 2 Unknown
NCT02630108 2016-10-18
TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Phase 3 Unknown
NCT02755311 2016-04-28
Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT02631499 2015-12-22
Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation
Fudan University
Phase 4 Unknown
NCT01964027 2013-10-17
SIEG
Anhui Medical University
Phase 2 Unknown
NCT00041262 2013-08-12
Combination Chemotherapy in Treating Patients With Esophageal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00843934 2012-10-19
ACE500
Nihon University
Phase 2/3 Unknown
NCT00075465 2008-07-24
Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
National Cancer Institute (NCI)
Phase 2 Unknown